Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
From Risk to Results: Cases in ASCVD Prevention and Treatment
When and Why to Use CAC Scoring
Statins and Safety: What the Data Say About Dementia, Cancer, and More
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
prof. Hiddo Heerspink
Jennifer B. Green, MD
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
John Ostrominski
NYHA FC and Finerenone Response: Clinical Trial Insights
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Implementing the SOC Induction Therapies in AAV
Bernhard Hellmich, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Managing Patients With AAV in the Rheumatology Clinic
Elevating Care for Patients With Severe Renal Disease in AAV
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.